Texas Sen. John Cornyn sounded the alarm that a biotech startup firm that has raised some $30 million to study diseases in ...
This comprehensive e-book from The Hindu explores how gene editing tools like CRISPR and synthetic biology are fundamentally changing what it means to be human and are giving us the power to modify ...
In response to the EU ruling, Apple revised its terms to impose fees ranging from 13% for smaller businesses to up to 20% ...
A centre of excellence for crop biotechnology is set be established to develop and deploy disease-resistant seeds under a new five-year project, according to the Ministry of Agriculture and Animal ...
TipRanks on MSN
Cellectis announces arbitral decision in Servier dispute
Cellectis SA ( ($CLLS) ) has provided an announcement. On December 15, 2025, Cellectis announced an arbitral decision regarding its dispute with ...
The Tribunal ruled on a partial termination of the License Agreement with respect to product UCART19 V1 (also referred to as “ALLO-501” by Allogene) and provided that Cellectis shall, at Allogene’s ...
In a new study, scientists at the Max Planck Institute for Evolutionary Anthropology in Leipzig analyzed the impact of more ...
Newly updated research shows incredible promise, but it's still just the beginning of the era of real cancer therapies.
Watson season 2 episode 10 airs December 15, 2025, on CBS. Find release time, streaming details on Paramount+, and what to ...
Gene editing can repair mutations that prematurely halt protein synthesis, resulting in incomplete peptides that cause ...
Discover top biotech companies for 2026, featuring emerging stars and leaders set for major clinical and regulatory ...
Climate Compass on MSN
CRISPR and the future: Can we edit out genetic diseases?
We're living in a moment where science fiction is becoming medical reality. Imagine a world where doctors can simply rewrite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results